7 minute read
Oct. 17, 2023

Divarasib: Great Timing for Positive Data Makes This KRAS Inhibitor a Big Deal


oral selective covalent KRASG12C inhibitor Ph. III for NSCLC from disulfide-tether fragment screen N. Engl. J. Med., August 2023 Genentech, So. San Francisco, CA


Molecules of the Month - August 2023

MOTY Nominees

Molecule of the Year